DMAC Financials
DiaMedica Therapeutics Inc - Financial statements & key metrics
Stock Price
$6.45
Market Cap
$157.38M
P/E Ratio
-10.8
EPS
$-0.71
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-24.44M
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$46.34M
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$3.02M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-22.08M
CapEx
-
Free Cash Flow
-
Profitability Metrics
00
ROE
-64.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is DMAC revenue?
View DMAC's income statement for detailed revenue data.
Is DMAC profitable?
DMAC reported a loss of $24.44M in the most recent quarter.
What is DMAC market cap?
DMAC has a market capitalization of $157.38M, making it a small-cap stock.
Does DMAC have debt?
View DMAC's balance sheet for debt information.
What is DMAC cash flow?
Cash flow data is available in the full financial statements.